Carson Wealth (CWM LLC)
FHTX icon

Carson Wealth (CWM LLC)’s Foghorn Therapeutics FHTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16K Buy
3,345
+1,996
+148% +$11K ﹤0.01% 4549
2025
Q4 		$7K Sell
1,349
-329
-20% -$1.49K ﹤0.01% 4694
2025
Q3 		$8K Sell
1,678
-352
-17% -$1.87K ﹤0.01% 4559
2025
Q2 		$10K Buy
2,030
+238
+13% +$995 ﹤0.01% 4288
2025
Q1 		$7K Buy
1,792
+1,774
+9,856% +$8.09K ﹤0.01% 4281
2024
Q4 		$0 Sell
18
-20
-53% -$146 ﹤0.01% 4981
2024
Q3 		$0 Buy
38
+21
+124% +$152 ﹤0.01% 4916
2024
Q2 		$0 Buy
17
+16
+1,600% +$95 ﹤0.01% 4693
2024
Q1 		$0 Buy
+1
New +$6 ﹤0.01% 4453

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s FHTX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Foghorn Therapeutics (FHTX) stake by 148% in Q1 2026, buying an estimated $11K and bringing the position to 3,345 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4549.

Carson Wealth (CWM LLC) first reported a position in FHTX in Q1 2024 and has held it in 9 quarters since. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 3,345 shares of Foghorn Therapeutics worth $16K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,996 Foghorn Therapeutics shares in Q1 2026, an estimated $11K.
  • Foghorn Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4549 holding.
  • Carson Wealth (CWM LLC) first reported a position in Foghorn Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.